Axcan Pharma Reviews

Recommend to a friend
Approve of CEO
(no image)
0 Ratings
  • Aptalis

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Manager in Birmingham, AL
    Former Employee - Manager in Birmingham, AL

    I worked at Axcan Pharma full-time (More than 3 years)

    Neutral Outlook
    Neutral Outlook


    Competitive pay
    Consistent company performance and incentive payouts
    Equity programs
    Benefits - cost and coverage


    Inexperienced CEO
    Very low work-life balance
    Mediocre product portfolio
    New Jersey headquarters

    Advice to Management

    Define strategy and follow it

Axcan Pharma Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Mont-Saint-Hilaire, Canada
Size 500 to 999 Employees
Founded Unknown
Type Company - Private
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (USD) per year

Aptalis Pharma knows its ABCs when it comes to treating CF and GI ailments. The company, formerly named Axcan Intermediate Holdings, develops and sells drugs mainly to treat cystic fibrosis (CF) and gastrointestinal (GI) conditions. Its Urso line treats liver disease; Carafate and Sulcrate treat ulcers; and Canasa and Salofalk offer relief for inflammatory bowel diseases. In addition, Aptalis Pharma markets Zenpep, a digestive aids for patients with exocrine pancreatic insufficiency, a condition associated with cystic fibrosis. The firm's products are primarily sold in... More

Work at Axcan Pharma? Share Your Experiences

Axcan Pharma

Click to Rate